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Abstract Introduction: For monitoring pulmonary edema secondary to Congestive Heart Failure (CHF),
we investigated trends of impedance between implanted electrodes. Methods: ICDs were implanted in 16
dogs and 5 sheep. Right ventricleswere paced (230–250 bpm) for severalweeks. Impedancewasmeasured
every hour along 4 intrathoracic, 2 intracardiac and 4 cardiogenic vectors. Cardiac function was assessed
biweekly by catheterization and echocardiography. Left Atrial Pressure (LAP) was measured daily by an
implanted sensor. Results: All animals developed CHF after 2–4weeks of pacing (EF, 52 vs. 34%; LVEDV, 65
vs. 97 ml; LVEDP, 7 vs. 16 mm Hg; LAV, 17 vs. 33 ml; LAP, 7 vs. 26 mm Hg). Impedance decreased during
CHF: LV-Can, 17 ± 9%; LV–RV, 15 ± 8%; LV–RA, 13 ± 6%; RV-Can, 13 ± 8%; RVcoil-Can, 8 ± 6%; RA-Can,
6± 6%. The LV-Can decrease was greatest and correlated well with LAP (r2 = 0.73). All impedances were
associated with circadian variability at the baseline, which diminished during CHF (5 ± 2% vs. 2 ± 1%).
In CHF, cardiogenic impedances displayed reduced peak-to-peak amplitude and increased fractionation.
Conclusions: As impedance decreased during CHF, left-heart trends were better correlated with LAP. Left-
heart vectors may improve the detection of CHF compared to sensing by right-heart leads alone. This
approach has important clinical implications for managing HF patients in ambulatory settings.
© 2012 Sharif University of Technology. Production and hosting by Elsevier B.V.
Open access under CC BY license.1. Introduction
Congestive heart failure is an imbalance in pump function,
in which the heart fails to maintain the circulation of blood
adequately. The most severe manifestation of CHF, Pulmonary
Edema (PE), develops when this imbalance causes an increase
in lung fluid secondary to leakage from pulmonary capillaries
into the interstitium and alveoli of the lung. Heart failure can
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Open access under CC BY license.be subdivided into systolic and diastolic dysfunction. Systolic
dysfunction is characterized by a dilated Left Ventricle (LV)with
impaired contractility, while diastolic dysfunction occurs in a
normal or intact left ventricle with impaired ability to relax
and receive, as well as eject, blood. In the United States and
other developed countries, heart failure is one of themost costly
diseases in healthcare budgets, with 70% of expenses going
to the treatment of acute heart failure decompensation [1–3].
Regular monitoring of heart failure patients, recommended in
management programs, has not shown a conclusive impact on
heart failure morbidity. Severe symptoms that typically lead
to hospitalization occur late in the HF evolution cycle [3]. For
example, PE or associated symptoms, such as dyspnea, was
observed only at an average of 3 days prior to the hospital
visit. Therefore, a reliable means of HF status monitoring is
needed to detect early decompensation and ideally to prevent
patient’s hospitalization. Intrathoracic impedance, utilizing a
Right Ventricular (RV) lead, has been shown to be a useful
sensor for monitoring PE secondary to CHF [4–7]. The dilation
of heart chambers (e.g. LA, RV or LV) or the accumulation
of fluid during pulmonary congestion will form a better
conductance, causing a corresponding decrease in intracardiac
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or intrathoracic impedance. In an attempt to understand how to
improve the detection of CHF onset, we investigated trends in
impedance measured between multiple implanted electrodes
in an experimental model of induced heart failure.
2. Methods
Biventricular ICDs were implanted in two animal models:
16 dogs and 5 sheep. Standard transvenous leads were used,
with the ICD-Can placed in the left pectoral region. Continuous
RV pacing (230–250 bpm) was applied over several weeks. The
ICD delivered, between pairs of electrodes, a train of current
charge-and voltage-balanced multiphasic pulses (amplitude
0.5–1mA; frequency 16 kHz), andmeasured the corresponding
voltage. Steady-state impedance was determined as the ratio
between measured voltage and injected current. Multiple
signals were measured through the ring (r), the coil (c) and
the device Can electrodes. The ICD device sampled the steady-
state impedance (Zs) every hour, and daily averages were
computed. All measurements were made while pacing was
temporarily halted. Stored data were automatically transferred
through wireless communication. As illustrated in Figure 1,
Zs was measured every hour along 2 intracardiac vectors:
RVring–LVring (1 − RV–LV) and LVring–RAring (2 − LV–RA)
and 4 intrathoracic: RVring-Case(3 − RV-Can), LVring-Can(4 −
LV-Can), RAring-Case(5−RA-Can) and RVcoil-Can(6−RVc-Can).
Continuous cardiogenic impedance (Zc) signals were recorded
and delivered over 3 bipolar (LVring–RAring (V1), RVring–LVring
(V2) and RVring–RVtip (V3)) and 1 quadripolar (RV–LV (V4))
vector configurations.
Cardiogenic impedance represented the instantaneous beat-
to-beat changes in impedance, as caused by the mechanical
contractions of the heart. Constant currents were injected and
voltages measured from the electrode configurations above. All
signals were sampled at 128 Hz. Daily averages were trended.
The circadian variability, defined as the difference between the
maximum Zs and the minimum Zs, between 0:00 and 23:59
on each day, was also monitored. In dogs, LV End-Diastolic
Volume (LVEDV), LV Ejection Fraction (LVEF), LV End-Diastolic
Pressure (LVEDP) and Left Atrial (LA) volume were measured
every 2 weeks. In N = 10 animals, Left-Atrial Pressure (LAP)
was measured daily, using an implantable IC sensor (HeartPODFigure 2: Implantable left-atrial pressure sensor.
Figure 3: Fluoroscopic image of RA, RV and LV leads along with LAP sensor.
Figure 4: Peak-to-peak and fractionation index for Zc .
- St. Jude Medical). Figure 1 shows the Zc vectors and Figure 2
provides details about the LAP sensor.
Figure 3 illustrates a typical placement of leads (including
the LAP lead) inside an animal’s thorax.
Cardiogenic impedance data were analyzed by processing
the peak-to-peak (ppA) amplitude of the signal and by assessing
the Fractionation Index (FI). If a notch was present on a slope, FI
was defined as the size of the notch, divided by the amplitude of
peak. As presented in Figure 4, for each cardiac cycle, FI = a/b.
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Vector 1Z baselinea () 1%Z baselineb (%) 1Z HF () 1%Z HF (%) % change in1Z
from baseline to HF
RVc-Case 5.38 9.13 1.42 2.63 73.60c
LVr-RAr 24.3 4.02 12.8 2.40 47.40c
RVr-LVr 16.0 2.95 7.19 1.52 55.04c
LVr-Case 15.7 4.14 9.13 2.83 41.87c
RAr-Case 19.8 6.15 7.79 2.60 60.72c
RVr-Case 10.1 3.79 3.96 1.71 60.60c
a 1Z: Change in Z from daytime to nighttime in.
b 1%Z: Percent change in Z from daytime to nighttime.
c p < 0.05.Table 2: Trends in cardiogenic impedance during HF.
Vector ppA healthy () ppA HF () ppA % change FI healthy FI HF FI – % responder rate LAP correlation coefficient
LVr-RAr 22.5 14.4 −34.4 0.17 0.43 100 −0.31
RV–LV Quad 1.87 1.01 −45.9 0.25 0.37 80 −0.75
RVr-LVr 28.1 17.0 −41.4 0.23 0.32 50 −0.68
RVr-RVt 45.9 15.7 −68.3 0.086 0.17 60 −0.76Figure 5: Changes in Zs trend inversely with LAP.
3. Results
All animals developed CHF after 2–4 weeks of pacing
from baseline, as evidenced by deterioration in function and
hemodynamics (LVEF, 52 vs. 34%; LVEDV, 65 vs. 97 ml; LVEDP,
7 vs. 16mmHg; LAV, 17 vs. 33ml; LAP, 7 vs. 26mmHg), clinical
symptoms or autopsy. All impedance vectors decreased during
CHF: LV-Can, 17% ± 9%; RV–LV, 15% ± 8%; LV–RA, 12% ± 6%;
RV-Can, 12% ± 8%; RVc-Can, 8% ± 6%; and RA-Can, 5% ± 6%.
Typical Zs impedance trends showed an increase during the
first 30 days after implant, as leads matured. The Zs impedance
then decreased according to percentages above, as the animal
was rapidly paced into HF. Animals typically recovered within
1–2 weeks after cessation of rapid pacing and Zs impedance
increased back to their baseline values. When animals were
administered diuretics (i.e. fulosemide), the intake had the
effect of significantly reducing the animal’s fluid content and
as a result of significantly increasing Zs of all six vectors.
The addition of an LV lead improved impedance sensitivity
to CHF with LV-Can highly sensitive compared to vectors based
on RV-Can, RVc-Can or RA-Can alone (P < 0.05). Z changes in
RV–LV and LV–RA vectors were also significant as compared to
RVc-Can or RA-Can (P < 0.05). In a linear regression model,
the impedance of the LV-Can vector correlated well with LAPtrends (r2 = 0.73± 0.12, N = 10), while RV-Can and RVc-Can
Zs were less correlated (r2 = 0.43±0.22 and r2 = 0.52±0.15,
respectively). The impedance of all vectors inversely trended
with left-atrial pressure. At the initiation of rapid pacing, the
LAP increased, followed by a gradual decrease in Zs impedances.
On average, the impedance lagged the LAP increase by 0.5–2
days. As shown in Figure 5, the change in the impedance of left-
side vectors tracked best the LAP trend. For ease of comparison,
note that Figure 5 shows the change in impedance with an
inverted sign. A different animal study has shown that during
animal recovery, the vector impedance trended back up to the
close vicinity of its original value [5]. On average, the recovery
in impedance occurred over an approximately 14-day period,
withmost of it taking place in the first 4 days [5]. The correlation
to LAP was preserved during recovery [5]. The initial step in
LAP may have been the result of our artificial HF model. As
with most animal models, this model is not a perfect replica of
clinical HF.
In all Zs vectors with statistical significance, the impedance
was lowest between midnight and 3 AM and highest between
noon and 3 PM. The circadian variability decreased with
worsening heart failure.
Table 1 summarizes the circadian variability results. The
circadian variationwas computed as the difference between the
maximum and minimum of the monitored parameter during
any particular day. The relative values were computed with
respect to the base value of the monitored parameter. The
table reflects the means for all animals. A visible morphology
change in Zc occurred within 1–2 days of pacing, progressing
throughout HF induction, as quantified by ppA reduction and
FI increase in all vectors. There was a significant (p < 0.05)
inverse correlation between LAP and ppA in Zc vectors. Table 2
summarizes daily average changes in ppA and FI with HF onset.
The changes were referred to the initial values prior to pacing.
The direction of changes was consistent as LAP increased. No
post-pacing data were included.
A significant decrease in ppAand increase in FI occurredwith
the onset of HF. Percent responder rate indicates the percentage
of animals whose FI increased with HF onset for a given vector.
Inverse correlation between ppA and LAP was observed in all
vectors, as demonstrated by negative correlation coefficients.
Figure 6 shows a representative example of reduction in ppA
and the appearance of fractionation notcheswithworseningHF.
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electrogram is displayed along with Zc .4. Conclusions
We observed a marked decrease in the impedance in all
vectors after CHF onset. The addition of left-side vectors
improved Z sensitivity and correlated well with LAP trends.
Diuretics had an immediate effect, by increasing the impedance
of all vectors. High variability between daytime and nighttime
impedancewas found, significantly decreasingwith onset ofHF.
Due to animal model limitations, it was not evident whether
the decrease in the circadian variability of impedance was
linked to HF progression or to regularized RP heart rate. Onset
of HF caused a significant decrease in ppA and an increase
in FI in all cardiogenic impedance vectors, in all animals. A
statistically significant inverse correlation between ppA and
LAP was observed in three cardiogenic impedance vectors.
The use of impedance for monitoring heart failure deserves
further investigation. It is important to note that some of these
results may not be reflective of clinical and human use of this
technology. Our particular model of inducing heart failure by
rapid RV pacing may have certain limitations.
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